№ lp_1_2_45810
Clinical guidance text outlining pharmacology, licensing limits, withdrawal risks, and a staged dose reduction schedule for discontinuing long-term zopiclone use, including a patient-held tapering record.
Year: not specified
Country: United Kingdom
Medication: Zopiclone
Therapeutic class: Hypnotic
Indication: Insomnia
Licensed use duration: Up to 4 weeks
Adult licensed dose: 7.5 mg at bedtime
Elderly licensed dose: 3.75–7.5 mg at bedtime
Off-licence use: Yes
Primary topic: Dose reduction and withdrawal
Withdrawal risks: Physical and psychological withdrawal symptoms
Target population: Adult patients using zopiclone long term
Recommended tapering pace: No faster than one change per week
Dose forms: 3.75 mg tablets, 7.5 mg tablets
Reference bodies: All Wales Medicines Strategy Group; NICE
Document components: Clinical guidance; tapering schedule; patient reduction record
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.